Mason Street Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-13,640
| Closed | -$274K | – | 78 |
|
|
2020
Q4 | $274K | Sell |
13,640
-78
| -0.6% | -$1.57K | ﹤0.01% | 1343 |
|
|
2020
Q3 | $257K | Buy |
13,718
+1,057
| +8% | +$19.8K | 0.01% | 1278 |
|
|
2020
Q2 | $284K | Buy |
12,661
+726
| +6% | +$16.3K | 0.01% | 1254 |
|
|
2020
Q1 | $177K | Hold |
11,935
| – | – | ﹤0.01% | 1305 |
|
|
2019
Q4 | $230K | Buy |
11,935
+229
| +2% | +$4.41K | ﹤0.01% | 1356 |
|
|
2019
Q3 | $232K | Sell |
11,706
-77
| -0.7% | -$1.53K | ﹤0.01% | 1336 |
|
|
2019
Q2 | $249K | Buy |
11,783
+680
| +6% | +$14.4K | 0.01% | 1301 |
|
|
2019
Q1 | $227K | Buy |
11,103
+366
| +3% | +$7.48K | ﹤0.01% | 1368 |
|
|
2018
Q4 | $214K | Buy |
10,737
+458
| +4% | +$9.13K | 0.01% | 1300 |
|
|
2018
Q3 | $198K | Sell |
10,279
-86
| -0.8% | -$1.66K | ﹤0.01% | 1376 |
|
|
2018
Q2 | $158K | Buy |
10,365
+544
| +6% | +$8.29K | ﹤0.01% | 1428 |
|
|
2018
Q1 | $184K | Buy |
9,821
+613
| +7% | +$11.5K | ﹤0.01% | 1358 |
|
|
2017
Q4 | $177K | Buy |
9,208
+199
| +2% | +$3.83K | ﹤0.01% | 1359 |
|
|
2017
Q3 | $161K | Buy |
9,009
+211
| +2% | +$3.77K | ﹤0.01% | 1367 |
|
|
2017
Q2 | $157K | Buy |
8,798
+404
| +5% | +$7.21K | ﹤0.01% | 1356 |
|
|
2017
Q1 | $122K | Buy |
8,394
+549
| +7% | +$7.98K | ﹤0.01% | 1398 |
|
|
2016
Q4 | $145K | Buy |
7,845
+1,389
| +22% | +$25.7K | ﹤0.01% | 1342 |
|
|
2016
Q3 | $122K | Buy |
+6,456
| New | +$122K | ﹤0.01% | 1343 |
|